V R Grann

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. ncbi request reprint Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: a population-based study
    V Sundararajan
    Division of Epidemiology, Joseph L. Mailman School of Public Health, PH-18-127, 630 West 168th Street, New York, NY 10032, USA
    Cancer J 7:213-8. 2001
  2. ncbi request reprint Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study
    Nicolle M Gatto
    Department of Epidemiology, Joseph L Mailman School of Public Health, Columbia University, New York, NY, USA
    J Natl Cancer Inst 95:230-6. 2003
  3. ncbi request reprint Radiation therapy, cardiac risk factors, and cardiac toxicity in early-stage breast cancer patients
    John J Doyle
    Department of Epidemiology, Mailman School of Public, College of Physicians and Surgeons, Columbia University, New York Presbyterian Hospital, New York, NY, USA
    Int J Radiat Oncol Biol Phys 68:82-93. 2007
  4. ncbi request reprint Racial disparities in treatment and survival of male breast cancer
    Katherine D Crew
    Department of Medicine and the Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    J Clin Oncol 25:1089-98. 2007
  5. doi request reprint Neutropenia in 6 ethnic groups from the Caribbean and the U.S
    Victor R Grann
    Department of Medicine, College of Physicians and Surgeons, Columbia University, New York City, New York 10032, USA
    Cancer 113:854-60. 2008
  6. ncbi request reprint Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients
    V R Grann
    Herbert Irving Comprehensive Cancer Center of Columbia University, School of Public Health, New York, NY 10032, USA
    J Clin Oncol 16:979-85. 1998
  7. pmc Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers
    Victor R Grann
    Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA
    Breast Cancer Res Treat 125:837-47. 2011
  8. ncbi request reprint Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma
    Victor R Grann
    Division of Medical Oncology, Department of Medicine, Columbia University Medical Center, New York, New York 10032, USA
    Cancer 103:2241-51. 2005
  9. ncbi request reprint Outcomes and diffusion of doxorubicin-based chemotherapy among elderly patients with aggressive non-Hodgkin lymphoma
    Victor R Grann
    Department of Medicine and the Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, New York, USA
    Cancer 107:1530-41. 2006
  10. pmc Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean
    Victor R Grann
    Departments of Medicine, Epidemiology, and Health Policy, Mailman School of Public Health, Columbia University, New York, NY 10032, USA
    Br J Haematol 143:288-93. 2008

Collaborators

Detail Information

Publications46

  1. ncbi request reprint Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: a population-based study
    V Sundararajan
    Division of Epidemiology, Joseph L. Mailman School of Public Health, PH-18-127, 630 West 168th Street, New York, NY 10032, USA
    Cancer J 7:213-8. 2001
    ..Efforts are needed to ensure that elderly and non-Hispanic black patients receive appropriate treatment...
  2. ncbi request reprint Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study
    Nicolle M Gatto
    Department of Epidemiology, Joseph L Mailman School of Public Health, Columbia University, New York, NY, USA
    J Natl Cancer Inst 95:230-6. 2003
    ..Although the risk of bowel perforation is often cited as a major factor in the choice between colonoscopy and sigmoidoscopy for colorectal screening, good estimates of the absolute and relative risks of perforation are lacking...
  3. ncbi request reprint Radiation therapy, cardiac risk factors, and cardiac toxicity in early-stage breast cancer patients
    John J Doyle
    Department of Epidemiology, Mailman School of Public, College of Physicians and Surgeons, Columbia University, New York Presbyterian Hospital, New York, NY, USA
    Int J Radiat Oncol Biol Phys 68:82-93. 2007
    ..We studied the cardiac effects of RT and the impact of pre-existing cardiac risk factors (CRFs) in a population-based sample of older patients with breast cancer...
  4. ncbi request reprint Racial disparities in treatment and survival of male breast cancer
    Katherine D Crew
    Department of Medicine and the Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    J Clin Oncol 25:1089-98. 2007
    ..We analyzed race and other predictors of treatment and survival among men with stage I-III breast cancer...
  5. doi request reprint Neutropenia in 6 ethnic groups from the Caribbean and the U.S
    Victor R Grann
    Department of Medicine, College of Physicians and Surgeons, Columbia University, New York City, New York 10032, USA
    Cancer 113:854-60. 2008
    ....
  6. ncbi request reprint Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients
    V R Grann
    Herbert Irving Comprehensive Cancer Center of Columbia University, School of Public Health, New York, NY 10032, USA
    J Clin Oncol 16:979-85. 1998
    ..Many question whether they should have prophylactic surgical procedures, ie, bilateral mastectomy and/or oophorectomy...
  7. pmc Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers
    Victor R Grann
    Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA
    Breast Cancer Res Treat 125:837-47. 2011
    ..Annual screening with MRI and mammography was the most effective strategy because it was associated with the longest quality-adjusted survival, but it was also very expensive...
  8. ncbi request reprint Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma
    Victor R Grann
    Division of Medical Oncology, Department of Medicine, Columbia University Medical Center, New York, New York 10032, USA
    Cancer 103:2241-51. 2005
    ..The objective of this study was to assess hormone receptor status as an independent predictor of survival in a population-based cohort of women with breast carcinoma who were followed for up to 11 years...
  9. ncbi request reprint Outcomes and diffusion of doxorubicin-based chemotherapy among elderly patients with aggressive non-Hodgkin lymphoma
    Victor R Grann
    Department of Medicine and the Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, New York, USA
    Cancer 107:1530-41. 2006
    ..In the past 25 years, clinical trials have demonstrated the benefits of chemotherapy for patients with aggressive non-Hodgkin lymphoma. The authors analyzed the predictors and outcomes of chemotherapy among elderly patients with lymphoma...
  10. pmc Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean
    Victor R Grann
    Departments of Medicine, Epidemiology, and Health Policy, Mailman School of Public Health, Columbia University, New York, NY 10032, USA
    Br J Haematol 143:288-93. 2008
    ..A better understanding of these associations may help to improve cancer outcomes among individuals of African ancestry...
  11. ncbi request reprint Barriers to minority participation in breast carcinoma prevention trials
    Victor R Grann
    Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York 10032, USA
    Cancer 104:374-9. 2005
    ..Less than 4% of participants in the previously conducted P1 (tamoxifen vs. placebo) trial were minority women. We, therefore, studied barriers to minority participation in STAR among black, white, and Hispanic women who completed an RAF...
  12. ncbi request reprint Population screening for cancer-related germline gene mutations
    Victor R Grann
    Health Outcomes Research, Herbert Irving Comprehensive Cancer Center and Clinical Medicine and Epidemiology, College of Physicians and Surgeons and Mailman School of Public Health, Columbia University, New York, NY 10032, USA
    Lancet Oncol 3:341-8. 2002
    ....
  13. doi request reprint Breast cancer-related preferences among women with and without BRCA mutations
    Victor R Grann
    Herbert Irving Comprehensive Cancer Center, Department of Medicine, and Joseph L Mailman School of Public Health, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    Breast Cancer Res Treat 119:177-84. 2010
    ..Our findings support the use of average-risk individuals' time trade-off preference ratings for health care policy development...
  14. ncbi request reprint Regional and racial disparities in breast cancer-specific mortality
    Victor Grann
    Department of Medicine, Columbia University, New York, NY 10021, USA
    Soc Sci Med 62:337-47. 2006
    ....
  15. ncbi request reprint Benefits and costs of screening Ashkenazi Jewish women for BRCA1 and BRCA2
    V R Grann
    School of Public Health, and Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    J Clin Oncol 17:494-500. 1999
    ..To determine the survival benefit and cost-effectiveness of screening Ashkenazi Jewish women for three specific BRCA1/2 gene mutations...
  16. ncbi request reprint Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study
    John J Doyle
    Department of Medicine and Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, 161 Ft Washington, Rm 1068, New York, NY 10032, USA
    J Clin Oncol 23:8597-605. 2005
    ..We studied the cardiac effects of chemotherapy in a population-based sample of breast cancer patients aged > or = 65 years with long-term follow-up...
  17. ncbi request reprint Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based study
    Vijaya Sundararajan
    Department of Epidemiology, Joseph L Mailman School of Public Health, College of Physicians and Surgeons, New York University, 630 W 168th St, New York, NY 10032, USA
    J Clin Oncol 20:173-8. 2002
    ..The purpose of this study is to assess the use of chemotherapy in elderly patients with advanced ovarian cancer...
  18. ncbi request reprint Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women
    Dawn L Hershman
    Department of Medicine and the Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons Columbia University, 161 Ft Washington Room 1068, New York, NY 10032, USA
    Breast Cancer Res Treat 99:313-21. 2006
    ..However, the occurrence of delay in the delivery of adjuvant therapy and its impact on prognosis is not well understood...
  19. ncbi request reprint Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis
    Victor R Grann
    Herbert Irving Comprehensive Cancer Center, Department of Medicine, College of Physicians and Surgeons, Columbia University, 630 W 168th Street, New York, NY 10032, USA
    J Clin Oncol 20:2520-9. 2002
    ..This study updates findings regarding the effects of prophylactic surgery, chemoprevention, and surveillance on the survival and quality-adjusted survival of women who test positive for BRCA1/2 mutations...
  20. ncbi request reprint Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer
    Vijaya Sundararajan
    Joseph L Mailman School of Public Health, The Herbert Irving Comprehensive Cancer Center, and College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA
    Ann Intern Med 136:349-57. 2002
    ..Although this treatment became the standard in 1990 following a National Institutes of Health Consensus Conference, among those at least 65 years of age it is less likely to be offered to older or nonwhite patients...
  21. ncbi request reprint Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation
    Kristin Anderson
    Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Joseph L Mailman School of Public Health, Columbia University, and New York Presbyterian Hospital, New York, New York 10032, USA
    Ann Intern Med 144:397-406. 2006
    ..For BRCA1 or BRCA2 mutation carriers, decision analysis indicates that prophylactic surgery or chemoprevention leads to better survival than surveillance alone...
  22. ncbi request reprint Breast biopsy and race/ethnicity among women without breast cancer
    Judith S Jacobson
    Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032, USA
    Cancer Detect Prev 30:129-33. 2006
    ....
  23. pmc Pancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancer
    John A Chabot
    Columbia University Mailman School of Public Health, 722 W 168th St, Rm 734, New York, NY 10032, USA
    J Clin Oncol 28:2058-63. 2010
    ..0 v 4.3 months) and had better quality of life than those who chose proteolytic enzyme treatment...
  24. ncbi request reprint Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival
    Dawn L Hershman
    Department of Medicine and the Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, New York, NY 10032, USA
    Int J Radiat Oncol Biol Phys 65:1353-60. 2006
    ..We investigated factors that influence the time interval between lumpectomy and RT, and the association between that interval and survival...
  25. doi request reprint Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma
    Dawn L Hershman
    Department of Medicine and the Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, NY, USA
    J Clin Oncol 26:3159-65. 2008
    ..We studied the cardiac effects of doxorubicin in a population-based sample of older patients with diffuse large B-cell lymphoma (DLBCL)...
  26. ncbi request reprint Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer
    Dawn Hershman
    Department of Medicine, Mailman School of Public Health, Columbia University, New York, New York, USA
    Cancer 107:2581-8. 2006
    ..However, to the authors' knowledge, the effect of the interval between surgery and the initiation of chemotherapy on survival has not been investigated...
  27. ncbi request reprint Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy
    Dawn Hershman
    Department of Medicine and Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    J Natl Cancer Inst 99:196-205. 2007
    ..Although these growth factors support chemotherapy, their long-term safety has not been evaluated. We studied the association between G-CSF use and incidence of leukemia in a population-based sample of breast cancer patients...
  28. doi request reprint Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer
    Dawn L Hershman
    Department of Medicine and the Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    J Natl Cancer Inst 100:199-206. 2008
    ..We investigated the association of surgeon-related factors with receipt of adjuvant radiotherapy after BCS...
  29. ncbi request reprint Duration of adjuvant chemotherapy for colon cancer and survival among the elderly
    Alfred I Neugut
    Department of Medicine and the Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, New York, NY 10032, USA
    J Clin Oncol 24:2368-75. 2006
    ..However, little is known about the predictors of, or the survival associated with, duration of chemotherapy in the community...
  30. ncbi request reprint Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer
    Dawn Hershman
    Department of Medicine and the Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, NY, USA
    J Natl Cancer Inst 95:1545-8. 2003
    ....
  31. ncbi request reprint Patterns and outcomes of chemotherapy for elderly patients with stage II ovarian cancer: a population-based study
    Dawn Hershman
    The Department of Medicine and the Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, New York, NY 10032, USA
    Gynecol Oncol 92:293-9. 2004
    ..The purpose of this study was to assess the patterns of use of chemotherapy in women with stage II ovarian cancer, and to compare the survival of treated and untreated patients aged 65+ years in a population-based sample...
  32. ncbi request reprint Management of colorectal cancer in elderly patients: focus on the cost of chemotherapy
    Matthew J Matasar
    Department of Medicine, New College of Physicians and Surgeons, Columbia University, New York, USA
    Drugs Aging 21:113-33. 2004
    ..Nonetheless, as the effects of these novel agents upon both outcomes and costs continue to be defined, both curative and palliative treatment of colorectal cancer in the elderly patient will become more sophisticated and effective...
  33. ncbi request reprint Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer
    Dawn Hershman
    Department of Medicine and the Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, 161 Fort Washington, New York, NY 10032, USA
    Gynecol Oncol 94:540-9. 2004
    ..We previously showed that only about half of women over the age of 65 years with this disease received platinum-based chemotherapy, and that the likelihood of receiving it decreases with age...
  34. ncbi request reprint Racial disparities in treatment and survival among women with early-stage breast cancer
    Dawn Hershman
    Department of Medicine and the Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, New York, NY, USA
    J Clin Oncol 23:6639-46. 2005
    ..We analyzed the association of race and survival with duration of treatment and number of treatment cycles among women receiving chemotherapy for early-stage breast cancer...
  35. ncbi request reprint Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study
    Alfred I Neugut
    Department of Medicine, Mailman School of Public Health, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    J Clin Oncol 20:2643-50. 2002
    ..We investigated the use of these treatments for stages II and III rectal cancer among the elderly and the effectiveness of these treatments on a population-based scale...
  36. ncbi request reprint Cancer outcomes at the Hufeland (complementary/alternative medicine) klinik: a best-case series review
    Judith S Jacobson
    Department of Epidemiology, Mailman School of Public Health, New York, NY 10032, USA
    Integr Cancer Ther 4:156-67. 2005
    ..A best-case series review is an efficient tool with which to screen complex complementary and alternative treatments for cancer as candidates for further study...
  37. pmc Comparing genetic ancestry and self-described race in african americans born in the United States and in Africa
    Rona Yaeger
    Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, USA
    Cancer Epidemiol Biomarkers Prev 17:1329-38. 2008
    ..Genetic classifications of ancestry may provide a more objective and accurate method of defining homogenous populations for the investigation of specific population-disease associations...
  38. pmc Predictors of survival after hepatic resection among patients with colorectal liver metastasis
    X Wang
    Department of Biomedical Informatics, College of Physicians and Surgeons, New York Presbyterian Hospital, Columbia University, New York, NY 10032, USA
    Br J Cancer 97:1606-12. 2007
    ..A substantial subgroup of patients with CLM who undergo hepatectomy experiences long-term survival. High hospital procedure volume and use of 5FU-based or HAI-based chemotherapy after resection were associated with improved prognosis...
  39. doi request reprint Arsenic exposure and anemia in Bangladesh: a population-based study
    Julia E Heck
    Department of Epidemiology, Mailman School of Public Health, College of Physicians and Surgeons, Columbia University, New York, NY, USA
    J Occup Environ Med 50:80-7. 2008
    ..The purpose of this study was to examine the association between arsenic exposure and anemia, based on blood hemoglobin concentration...
  40. ncbi request reprint Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer
    J S Jacobson
    Herbert Irving Comprehensive Cancer Center and Joseph L. Mailman School of Public Health, Columbia University, and Weill-Cornell Medical College, New York, NY 10032, USA
    J Clin Oncol 19:2739-45. 2001
    ..Our study illustrates the feasibility and value of standard clinical trial methodology in assessing the efficacy and safety of herbal agents...
  41. ncbi request reprint Facilitating cancer research using natural language processing of pathology reports
    Hua Xu
    Department of Biomedical Informatics, College of Physicians and Surgeons, Columbia University, 622 W 168th Street, VC 5, New York, NY 10032, USA
    Stud Health Technol Inform 107:565-72. 2004
    ..The evaluation outcome showed that the extended NLP system had a sensitivity of 90.6% and a precision of 91.6%. Results indicated that this system performed satisfactorily for capturing information for the cancer research project...
  42. ncbi request reprint Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: a cost-effectiveness analysis
    Dawn Hershman
    Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Joseph L Mailman School of Public Health, Columbia University, 630 West 168th St, New York, NY 10032, USA
    J Clin Oncol 20:9-16. 2002
    ..To estimate the effects on survival, quality-adjusted survival, and health care costs of using tamoxifen for primary prevention in subgroups of women at very high risk for breast cancer...
  43. ncbi request reprint Completion rates of adjuvant chemotherapy for colon cancer: a historical perspective
    Victor R Grann
    J Natl Cancer Inst 98:570-1. 2006
  44. ncbi request reprint Referral to medical oncologists: are there barriers at the gate?
    Alfred I Neugut
    J Clin Oncol 20:1716-8. 2002
  45. ncbi request reprint Health insurance and cancer survival
    Victor R Grann
    Arch Intern Med 163:2123-4. 2003
  46. ncbi request reprint The case for randomized trials in cancer treatment: new is not always better
    Alison Grann
    JAMA 293:1001-3. 2005